Trial intelligence / Profile preview

Vitamin-D for Remission Maintenance in Crohn's Disease

NCT00132184Phase 3Unknown

Sponsor
Aarhus University
Start
Sep 2005
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in Crohn's disease comparing Vitamin D with Placebo (2 arms). Primary endpoint: Relapse rate within 1 year treatment; CDAI>220. Status: unknown.

02

Drugs

vitamin d
03

Conditions

Crohn's disease

Beyond the preview

Go deeper on NCT00132184.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00132184.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call